In BC, they rather act as mitogens to enhance tumourigenesis via either pathway: insulin, via the insulin receptor substrate 1 (IRS-1) and IGF-1, by binding to its own receptor (IGF1R) [46] (Figure 1). The gene discussed is IGF1; the disease is breast cancer.